Publikationen, an denen er mitarbeitet Jesús Guinea (11)

2023

  1. A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic

    BMC Microbiology, Vol. 23, Núm. 1

  2. First Report of Neocucurbitaria unguis-hominis Keratitis

    Journal of Fungi, Vol. 9, Núm. 1

2022

  1. Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers

    Microbiology Spectrum, Vol. 10, Núm. 1

  2. ΔF659 and F659S substitutions at the HS1 of FKS2 gene, along with E655A and W715L upstream and downstream substitutions, correlate with high ibrexafungerp MICs against Candida glabrata

    Clinical Microbiology and Infection, Vol. 28, Núm. 8, pp. 1154.e5-1154.e8

2021

  1. Antifungal susceptibility testing identifies the abdominal cavity as a source of candida glabrata-resistant isolates

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 12

2020

  1. Susceptibility of uncommon Candida species to systemic antifungals by the EUCAST methodology

    Medical mycology, Vol. 58, Núm. 6, pp. 848-851

2019

  1. Fatal disseminated infection by Gymnascella hyalinospora in a heart transplant recipient

    Transplant Infectious Disease, Vol. 21, Núm. 5

2017

  1. The misleading effect of serum galactomannan testing in high-risk haematology patients receiving prophylaxis with micafungin

    Clinical Microbiology and Infection, Vol. 23, Núm. 12, pp. 1000.e1-1000.e4

2014

  1. Is catheter-related candidemia a polyclonal infection?

    Medical Mycology

  2. Is it feasible to diagnose catheter-related candidemia without catheter withdrawal?

    Medical Mycology, Vol. 52, Núm. 5, pp. 489-495

2009

  1. Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?

    Intensive Care Medicine, Vol. 35, Núm. 4, pp. 707-712